AND — Andlauer Healthcare Income Statement
0.000.00%
- CA$2.08bn
- CA$2.20bn
- CA$650.48m
- 93
- 36
- 64
- 71
Annual income statement for Andlauer Healthcare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 314 | 440 | 648 | 648 | 650 |
| Cost of Revenue | |||||
| Gross Profit | 183 | 238 | 326 | 319 | 218 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 263 | 366 | 538 | 552 | 557 |
| Operating Profit | 50.9 | 73.7 | 110 | 96.1 | 94 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 46.6 | 108 | 104 | 90.6 | 88.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 37.7 | 90 | 76.3 | 66.1 | 64.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 37.7 | 90 | 76.3 | 66.1 | 64.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 37.7 | 90 | 76.3 | 66.1 | 64.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.98 | 2.25 | 1.79 | 1.55 | 1.57 |
| Dividends per Share |